Amarin Corp Plc (AMRN)

[north40000]

Amarin needs to increase the number of patients in the U.S. and the rest of world who are prescribed Vascepa to reduce risks from CVDs.

This week PLTR/ORCL and CDIO/Navierre have established a pair of separate collaborations that are designed to make AI-driven diagnostic algorithms for detecting patient risks of CVDs available to those patients who live in less-populated rural areas. Potential patients( e.g., those in wheelchairs that may have such risks) simply have not been driven/travelled to urban areas of USA to obtain the use of trained cardiology clinicians and complex/expensive imaging devices. We have seen here that trained cardiologists do/will prescribe Vascepa by email to pharmacies in urban areas for patients or caregivers to pickup.